Cargando…
A γ-Secretase Inhibitor, but Not a γ-Secretase Modulator, Induced Defects in BDNF Axonal Trafficking and Signaling: Evidence for a Role for APP
Clues to Alzheimer disease (AD) pathogenesis come from a variety of different sources including studies of clinical and neuropathological features, biomarkers, genomics and animal and cellular models. An important role for amyloid precursor protein (APP) and its processing has emerged and considerab...
Autores principales: | Weissmiller, April M., Natera-Naranjo, Orlangie, Reyna, Sol M., Pearn, Matthew L., Zhao, Xiaobei, Nguyen, Phuong, Cheng, Soan, Goldstein, Lawrence S. B., Tanzi, Rudolph E., Wagner, Steven L., Mobley, William C., Wu, Chengbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339551/ https://www.ncbi.nlm.nih.gov/pubmed/25710492 http://dx.doi.org/10.1371/journal.pone.0118379 |
Ejemplares similares
-
Substrate docking to γ-secretase allows access of γ-secretase modulators to an allosteric site
por: Uemura, Kengo, et al.
Publicado: (2010) -
Presenilin/γ-Secretase and Inflammation
por: Saura, Carlos A.
Publicado: (2010) -
γ-Secretase in Alzheimer’s disease
por: Hur, Ji-Yeun
Publicado: (2022) -
Pharmacological and Toxicological Properties of the Potent Oral γ-Secretase Modulator BPN-15606
por: Wagner, Steven L., et al.
Publicado: (2017) -
Soluble γ-Secretase Modulators Selectively Inhibit the Production of the 42-Amino Acid Amyloid β Peptide Variant and Augment the Production of Multiple Carboxy-Truncated Amyloid β Species
por: Wagner, Steven L., et al.
Publicado: (2014)